>

Risorse

Trovate qui tutte le informazioni importanti sul nostro settore e sulla donazione di plasma. Potrete consultare articoli affidabili e di valore, ricchi di informazioni e riflessioni interessanti.

Cerca materiale

Collegamenti rapidi

Link per i membri

Quality Standards of Excellence, Assurance and Leadership (QSEAL)

Quality Standards of Excellence, Assurance and Leadership (QSEAL)

International Plasma Awareness Week 2022: Donate Locally. Think Globally.

International Plasma Awareness Week 2022: Donate Locally. Think Globally.

A missed opportunity to acknowledge EU’s dependency on U.S. plasma

A missed opportunity to acknowledge EU’s dependency on U.S. plasma

Link per i pazienti

Patient Notification System (PNS)

Patient Notification System (PNS)

Immunoglobulin Access Materials

Immunoglobulin Access Materials

Altri link

THE SOURCE: Spring 2025

THE SOURCE: Spring 2025

PPTA Donor History Questionnaire

PPTA Donor History Questionnaire

Pathogen Safety

Pathogen Safety

National Donor Deferral Registry (NDDR®)

National Donor Deferral Registry (NDDR®)

Categorie

Raccolta e lavorazione del plasma

Scopri di più sulla raccolta del plasma e trova i centri certificati per la raccolta del plasma più vicini a te.

Schede informative

Le schede informative forniscono ulteriori informazioni sull'industria terapeutica globale delle proteine plasmatiche.

Risorse per i pazienti

Esplora le risorse del PPTA per i pazienti interessati alle terapie a base di proteine plasmatiche.

Terapie del Plasma

Learn more about plasma protein therapies and their immense value to patients.

Rapporti degli stakeholder

Accedi alla raccolta di rapporti di settore.

Domande frequenti sul plasma

Ottieni risposte sulle terapie a base di plasma e sui processi di donazione e raccolta.

Sensibilizzazione

Scopri di più sulle iniziative di sensibilizzazione dell'Associazione per garantire ai pazienti l'accesso alle terapie.

Novità e comunicati stampa

Rimani al corrente delle novità e degli eventi dell'Associazione.

Accesso alle cure

Consulta il registro completo dei problemi di accesso alle cure per regione e le attività del PPTA a sostegno dell'accesso alle terapie.

Post del blog

Una raccolta di post del blog

Rivista The Source

Iscriviti alla rivista internazionale dell'industria terapeutica delle proteine plasmatiche,

Pubblicazioni & presentazioni

Discover the main highlights of our industry in our latest publications.

Sicurezza & Qualità

Approfondisci le normative e gli standard volontari dell'Associazione per le norme di sicurezza e qualità.

Together toward a broader European plasma donation ecosystem

Strengthening the EU Blood Directive: To meet the needs of patients using plasma-derived medicinal products and plasma donors

Together toward a broader European plasma donation ecosystem

https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453f652d7ca1569557512dc_PPTA%20Position%20Paper%20on%20the%20EU%20BTC%20revision_September2021.pdf

Together toward a broader European plasma donation ecosystem

Strengthening the EU Blood Directive: To meet the needs of patients using plasma-derived medicinal products and plasma donors

Together toward a broader European plasma donation ecosystem

https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453f652d7ca1569557512dc_PPTA%20Position%20Paper%20on%20the%20EU%20BTC%20revision_September2021.pdf

Plasmavigilance-Adverse events among US Source plasma donors

Source plasma (SP) is the primary starting material for 87% of plasma-derived medicinal products globally. Plasmavigilance is a program designed to collect, analyze, and monitor donor adverse events (AEs) across the SP collection industry.

Plasmavigilance-Adverse events among US Source plasma donors

https://pubmed.ncbi.nlm.nih.gov/34390267/

Plasmavigilance-Adverse events among US Source plasma donors

Source plasma (SP) is the primary starting material for 87% of plasma-derived medicinal products globally. Plasmavigilance is a program designed to collect, analyze, and monitor donor adverse events (AEs) across the SP collection industry.

Plasmavigilance-Adverse events among US Source plasma donors

https://pubmed.ncbi.nlm.nih.gov/34390267/

Plasma donations remain disappointingly low through ongoing pandemic, risking patients’ lives

The Plasma Protein Therapeutics Association (PPTA) is aware of emerging reports regarding patients not having reliable access to lifesaving plasma-derived therapies used to treat a variety of serious, rare, and chronic conditions caused by missing or deficient proteins in their blood.

PPTA statements

Plasma donations remain disappointingly low through ongoing pandemic, risking patients’ lives

Plasma donations remain disappointingly low through ongoing pandemic, risking patients’ lives

The Plasma Protein Therapeutics Association (PPTA) is aware of emerging reports regarding patients not having reliable access to lifesaving plasma-derived therapies used to treat a variety of serious, rare, and chronic conditions caused by missing or deficient proteins in their blood.

PPTA statements

Plasma donations remain disappointingly low through ongoing pandemic, risking patients’ lives

The Source Fall 2021

Magazine of the plasma protein therapeutics industry - Fall 2021

The Source Magazine

The Source Fall 2021

https://drive.google.com/file/d/18ZMDuw0MnmyjHMdEOtrm6hWU9lt5JRMF/view?usp=sharing

The Source Fall 2021

Magazine of the plasma protein therapeutics industry - Fall 2021

The Source Magazine

The Source Fall 2021

https://drive.google.com/file/d/18ZMDuw0MnmyjHMdEOtrm6hWU9lt5JRMF/view?usp=sharing

No results found